Systemic Therapy Clinical Trials in Beijing, None Selected
2 recruitingBeijing, None Selected, China
Showing 1–2 of 2 trials
Recruiting
Not Applicable
TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
Hepatocellular CarcinomaSystemic TherapyPortal Vein Tumor Thrombus
Sun Yat-sen University42 enrolled1 locationNCT06622031
Recruiting
Not Applicable
The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma
AblationSystemic TherapyRecurrent Hepatocellular Carcinoma+2 more
Sun Yat-sen University116 enrolled1 locationNCT06609850